Indometacin Market

Indometacin, or indomethacin, is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic properties. NSAIDs consist of agents that are structurally unrelated; the NSAID chemical classification of indometacin is an indole-acetic acid derivative with the chemical name 1- (p-chlorobenzoyl)25-methoxy-2-methylindole-3-acetic acid.The pharmacological effect of indometacin is not fully understood, however, it is thought to be mediated through potent and nonselective inhibition of the enzyme cyclooxygenase (COX), which is the main enzyme responsible for catalyzes the rate-limiting step in prostaglandin and thromboxane biosynthesis via the arachidonic acid (AA) pathway.

Indometacin Market contains market size and forecasts of Indometacin (Indomethacin) in Global, including the following market information:

Global Indometacin (Indomethacin) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Indometacin (Indomethacin) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Indometacin (Indomethacin) include Iroko Pharma, Zyla Life Sciences, Kowa, Merck, H. Lumdbeck, Recordati, Druggability Technologies, AlphaRx and Cypress Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Indometacin (Indomethacin) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Indometacin (Indomethacin) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Indometacin (Indomethacin) Market Segment Percentages, by Type, 2021 (%)

Tablet

Capsule

Suppository

Injection

Patch

Gelatin Pearl

Cream

Other

Global Indometacin (Indomethacin) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Indometacin (Indomethacin) Market Segment Percentages, by Application, 2021 (%)

Nonsteroidal Anti-Inflammatory Drugs

Topical Administration For Joint And Muscle Pain

Western Medicine Carcinogenic Pain Medicine

Dysmenorrheal

Batter Syndrome

Other

Global Indometacin (Indomethacin) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Indometacin (Indomethacin) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Indometacin (Indomethacin) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Indometacin (Indomethacin) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Iroko Pharma

Zyla Life Sciences

Kowa

Merck

H. Lumdbeck

Recordati

Druggability Technologies

AlphaRx

Cypress Bioscience

NAL Pharma

Dr. Reddy?s

Provalis

NIPRO

Shanghai Modern Pharmaceutical

Beijing Shuangji Pharmaceutical

Sinopharm Group Industry

Jiangsu Yuanheng Pharmaceutical

Hubei Dongxin Pharmaceutical

Ma Yinglong Pharmaceutical Group

Shanghai New Yellow River Pharmaceutical Co. , Ltd.

JBH Pharmaceutical Group

Linfen Baozhu Pharmaceutical

Shanxi Yunpeng Pharmaceutical

Shanxi Taiyuan Pharmaceutical

Guangdong Sancai Shiqi District Pharmaceutical

Guangdong South China Pharmaceutical Group

Jiangsu Yabang Aipusen Pharmaceutical

Chongqing Kerui Pharmaceutical Group

Beijing Honglin Pharmaceutical

Suzhou No. 3 Pharmaceutical Factory

Bedford Pharma

Northwind Pharmaceuticals

PD-Rx Pharmaceuticals